A detailed history of Lagoda Investment Management, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Lagoda Investment Management, L.P. holds 2,300 shares of NVO stock, worth $234,002. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,300
Previous 3,780 39.15%
Holding current value
$234,002
Previous $539,000 49.35%
% of portfolio
0.16%
Previous 0.31%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $176,223 - $215,221
-1,480 Reduced 39.15%
2,300 $273,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $180,970 - $397,084
1,990 Added 111.17%
3,780 $343,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $38,995 - $43,162
250 Added 16.23%
1,790 $289,000
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $73,323 - $96,760
-715 Reduced 31.71%
1,540 $208,000
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $4,040 - $4,541
-85 Reduced 3.63%
2,255 $117,000
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $42,812 - $48,010
-915 Reduced 28.11%
2,340 $119,000
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $6,954 - $7,894
-150 Reduced 4.41%
3,255 $170,000
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $13.8 Million - $15.7 Million
-333,265 Reduced 98.99%
3,405 $157,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $488,688 - $535,509
10,451 Added 3.2%
336,670 $15.9 Million
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $2.59 Million - $2.95 Million
-58,538 Reduced 15.21%
326,219 $15 Million
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $1.68 Million - $2.01 Million
-34,563 Reduced 8.24%
384,757 $18.9 Million
Q4 2017

Feb 14, 2018

SELL
$47.53 - $53.73 $190 - $214
-4 Reduced -0.0%
419,320 $22.5 Million
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $17.3 Million - $20.6 Million
419,324
419,324 $20.2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lagoda Investment Management, L.P. Portfolio

Follow Lagoda Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lagoda Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Lagoda Investment Management, L.P. with notifications on news.